Clinical trials: Melasma
Melasma, Facial Melasma
Injectable Platelet-Rich Fibrin Versus Intradermal Tranexamic Acid for Melasma
Melasma is a chronic acquired hyperpigmentation disorder that commonly affects the face and has a significant impact on quality of life.
- Trial name
- NCT07540702
- Testing
- Injectable Platelet-Rich Fibrin, Tranexamic acid 100 mg/mL (Kapron)
- Where
- Egypt
- Volunteers
- 21 people
- Sponsor
- Kasr El Aini Hospital
Melasma
Revlite Laser System Compared to the Candela Alex TriVantage System Refractory Mixed Type Melasma
This proof of concept study will be conducted to assess the aesthetic improvement in refractory mixed type melasma in subjects treated with two FDA 510K approved devices: Q Switched Nd: YAG Laser vs. Alex TriVantage
- Trial name
- NCT01745224
- Testing
- Revlite Q switched Nd:YAG, Trivantage Q switched Nd: YAG
- Where
- United States
- Volunteers
- 4 people
- Sponsor
- Cynosure, Inc.